SBI Securities’s Verona Pharma VRNA Stock Holding History

SBI Securities’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-73	Closed	-$7.79K	–	4238
2025 Q3	$7.79K	Sell	73 -691	-90%	-$72.2K	﹤0.01%	1878
2025 Q2	$72.3K	Buy	764 +562	+278%	+$41.6K	﹤0.01%	922
2025 Q1	$12.8K	Buy	202 +191	+1,736%	+$11.4K	﹤0.01%	1504
2024 Q4	$511	Buy	+11	New	+$413	﹤0.01%	2881

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

SBI Securities's VRNA Position: Q4 2025 in Review

SBI Securities sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 73 shares — an estimated $7.79K sold.

SBI Securities first reported a position in VRNA in Q4 2024 and held it in 4 quarters. The position peaked at $72.3K in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

SBI Securities reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 73 Verona Pharma shares in Q4 2025, an estimated $7.79K.
SBI Securities first reported a position in Verona Pharma in Q4 2024 and held it in 4 quarters.
SBI Securities's Verona Pharma position peaked at $72.3K in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.